A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease) | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease) | stella

Back to Liver Cancer (Primary and Metastatic) trials

Recruiting

Plain-English translation of NCT07820644 on ClinicalTrials.gov ↗ · Source last updated September 2026 · How we translate trials

Trial locations(1 site)

China

The Third People's Hospital of Shenzhen, Shenzhen, Guangdong

Key details

Sponsor

Cai Qingxian

Enrollment target

~15,000 participants

Started

June 2026

Primary completion

March 2030

Age range

18 Years – 75 Years

Last updated on clinicaltrials.gov in September 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Dongmei Gou, Dr

Cai Qingxian

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.